Related Experiment Videos
Advances in atherosclerosis
1University of Western Ontario, London, Canada.
Insights
Recent advances in understanding atherosclerosis, particularly the role of lipids and endothelial function, are improving patient outcomes. New insights into risk factors and plaque stabilization offer powerful therapeutic strategies for vascular disease.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Lipidology
Background:
- Atherosclerosis understanding has been revolutionized by recent scientific breakthroughs.
- Lipid-lowering therapies demonstrate significant benefits beyond stenosis regression.
Purpose of the Study:
- To review major advances in atherosclerosis research.
- To highlight the impact of new knowledge on clinical practice and patient care.
Main Methods:
- Meta-analyses and large clinical trials of hyperlipidemia treatments.
- Investigation into novel risk factors including apolipoproteins, lipoprotein (a), and endothelial dysfunction.
Main Results:
- Lipid-modifying treatments reduce coronary and overall mortality, with event reduction preceding plaque regression.
- Plaque stabilization and reversal of endothelial dysfunction are key mechanisms.
- Advances in understanding genetics, inflammation, and hemodynamic factors are crucial.
Conclusions:
- A paradigm shift in comprehending atherosclerosis, driven by endothelial function insights.
- New therapeutic avenues are emerging for vascular medicine and neurology.
- Improved patient management strategies are anticipated due to enhanced understanding of risk factors and arterial remodeling.
Abstract:
In the past few years major advances have changed the way we think about atherosclerosis. Treatments for hyperlipidaemia not only regress angiographic stenosis and reduce coronary mortality; in meta-analysis, and in large trials of secondary prevention, they appear to reduce overall mortality. Reduction in events precedes regression of stenosis, partly through stabilization of plaque, and partly by reversal of the endothelial dysfunction caused by oxidized LDL. The study of lipid disorders has been advanced by new understanding of the role of apolipoproteins and lipoprotein (a). Significant advances have also been made in the understanding of effects of angiotensin, fibrinogen, homocysteinaemia, platelets, genetics of atherosclerosis, autoimmunity, flow disturbances and wall stress. Most importantly, because of a revolution in our understanding of the endothelium, we can now begin to make sense of some of the effects of risk factors such as lipids, menopause, flow disturbances, and pressure, to begin to understand atherosclerosis, arterial remodelling and the protective effect of oestrogen in a new light. These changes will profoundly affect the way we practise vascular medicine and neurology, and will give us powerful new ways to help our patients.